Obstetrician-gynecologists’ practice patterns regarding hpv testing in cervical cancer screening in turkey Türkiye’de kadın hastalıkları ve doğum uzmanlarının serviks kanseri taramasında hpv testi ile ilgili uygulama paternleri


Aktaş B. A., TOPTAŞ T., ÜREYEN I., DOĞAN S., Uysal A.

Turkish Journal of Obstetrics and Gynecology, cilt.18, sa.1, ss.15-22, 2021 (ESCI, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 18 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.4274/tjod.galenos.2021.36418
  • Dergi Adı: Turkish Journal of Obstetrics and Gynecology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.15-22
  • Anahtar Kelimeler: Cervical cancer, human papillomavirus, HPV test
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: To determine obstetrician-gynecologists’ (OBGYNs) practice patterns regarding human papillomavirus (HPV) testing in cervical cancer screening. Secondly, we aimed to examine OBGYNs’ adherence to guidelines in the management of women with HPV-positive test results. Materials and Methods: The study was a cross-sectional survey conducted in Antalya and Istanbul provinces in Turkey using a self-reported questionnaire. A 12-item questionnaire form was administered to the participants in face-to-face interviews. Of the targeted participants, 343 OBGYNs completed the questionnaire. Results: The majority of participants, (81.0%) stated that they offered/used HPV testing in cervical cancer screening. Of those, most OBGYNs (89.9%) preferred to use HPV testing concomitant with cervical cytology (co-testing) whereas only 10.1% preferred to use HPV testing alone (primary HPV testing). The most preferred screening intervals for women with HPV-negative results were 5 years (53.4%) and 3 years (19.9%), respectively. In compliance with the guidelines, the rate of participants who recommended “referral directly to colposcopy” for women who were HPV16/18-positive and cytology-negative; and “co-testing at 12 months” for women who were positive for HPV genotypes other than HPV16/18 and cytology-negative was 53.1%. Multivariate analysis revealed that the “professional working setting” was the sole independent determinant of the adherence to the guidelines. OBGYNs working in private settings had the worst adherence rate (42.4%). Conclusion: Primary HPV testing is not yet widespread among Turkish OBGYNs. Moreover, adherence to practice guidelines in the management of HPV-positive test results is relatively low. There is a need for continuing medical education regarding screening programs and the management of women with positive screening results.